A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

NCT05526248 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Biochemically Recurrent Prostate Cancer

Interventions

DRUG: Darolutamide(BAY1841788, Nubeqa)
DRUG: Enzalutamide

Sponsor

Bayer